Discontinuing Nasal Continuous Positive Airway Pressure in Infants ≤32 Weeks of Gestational Age: A Randomized Control Trial.

Objectives: To compare immediate cessation of nasal continuous positive airway pressure (NCPAP) vs a stepwise decrease in pressure on the duration of NCPAP therapy in infants born prematurely.

Study Design: A single center study in infants 23-32 weeks of gestational age. NCPAP was stopped either at 5 cm HO (control) or 3 cm HO after a stepwise pressure wean (wean) using defined stability and failure criteria.